Aytu Biopharma (AYTU) Accounts Payables (2011 - 2026)
Aytu Biopharma (AYTU) posted quarterly Accounts Payables of $13.2 million for Q1 2026, up 9.74% year-over-year from $12.0 million in Q1 2025, and down 7.33% quarter-over-quarter from $14.3 million in Q4 2025.
Aytu Biopharma (AYTU) Accounts Payables (2011 - 2026) Analysis & Trends
Aytu Biopharma (AYTU) has reported Accounts Payables for 15 consecutive years, with $13.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Accounts Payables rose 9.74% year-over-year to $13.2 million; the TTM figure through Mar 2026 stood at $13.2 million (up 9.74% YoY), while the FY2025 annual figure was $10.6 million, up 2.78% from the prior year.
- Accounts Payables fell to $13.2 million in Q1 2026 per AYTU's latest filing, from $14.3 million in the prior quarter.
- Across five years, Accounts Payables topped out at $14.3 million in Q4 2025 and bottomed at $10.3 million in Q2 2024.
- Historically, Accounts Payables has averaged $12.0 million across 4 years, with a median of $12.0 million in 2025.
- Annual changes were most pronounced in 2024 — Accounts Payables retreated 23.48% — and 2025, when it grew 21.88%.
- Aytu Biopharma's Accounts Payables stood at $10.5 million in 2023, then climbed by 11.71% to $11.7 million in 2024, then increased by 21.88% to $14.3 million in 2025, then fell by 7.33% to $13.2 million in 2026.
- Business Quant data shows AYTU's Accounts Payables at $13.2 million in Q1 2026, $14.3 million in Q4 2025, and $12.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | -5.09 Bn |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 2.72 Bn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | 452.00 Mn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | 2.80 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | 497.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 1.73 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 808.30 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 427.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 356.00 Mn |
| 10 | Aytu Biopharma | 24.70 Mn | -2.01 Mn | 7.60 Mn | 13.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.21 Mn |
| Dec 31, 2025 | 14.26 Mn |
| Sep 30, 2025 | 12.34 Mn |
| Jun 30, 2025 | 10.60 Mn |
| Mar 31, 2025 | 12.04 Mn |
| Dec 31, 2024 | 11.70 Mn |
| Sep 30, 2024 | 13.51 Mn |
| Jun 30, 2024 | 10.31 Mn |
| Mar 31, 2024 | 10.48 Mn |
| Dec 31, 2023 | 10.47 Mn |
| Jun 30, 2023 | 13.48 Mn |
| Jun 30, 2021 | 19.26 Mn |
| Dec 31, 2020 | 7.16 Mn |
| Sep 30, 2020 | 5.77 Mn |
| Jun 30, 2020 | 11.64 Mn |
| Mar 31, 2020 | 6.96 Mn |
| Dec 31, 2019 | 9.60 Mn |
| Sep 30, 2019 | 2.63 Mn |
| Jun 30, 2019 | 2.13 Mn |
| Mar 31, 2019 | 2.13 Mn |